For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson & Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.
EMD Serono refreshed its "Birds & Bees" fertility issues awareness campaign with a Facebook page and a music video.
GlaxoSmithKline launched new commercials for Alli, in time for New Year's resolutions and holiday overeating remorse, and handed off five OTC products to Meda Pharmaceuticals.
AstraZeneca launched the first consumer TV and print ads for Seroquel XR for bipolar depression, playing on the all-consuming way in which patients experience the disease.
If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
Pfizer passed Chantix creative work to McGarryBowen, ending McCann HumanCare's contract on the smoking cessation drug, agency sources confirmed.
Wyeth Consumer Health has launched a TV and print ad campaign for Advil advising consumers that they can do more with fewer bottles of OTC pain meds clogging up their purses, thanks to "The Every Pain Reliever."
GlaxoSmithKline has signed country singer Wynonna Judd to serve as the face of its OTC weight loss drug Alli.
In a reminder that the new media world is not without its perils, Johnson & Johnson is backpedaling from a Motrin campaign about slings aimed at moms that drew arrows from the Stroller Mafia.
Dusa's ClindaReach professional ads, created by Topin & Associates, snagged three awards at the AMM's Doctors' Choice Awards luncheon.
Nine months after it pulled Chantix DTC amid concern about possible psychiatric side effects, Pfizer's tortoise and hare are back on the air with a new 90-second TV spot long on risk information.
The AMM's Doctors' Choice awards has announced 13 finalists. Winners will be announced at a luncheon on September 24.
It was a plot point on a famous episode of Seinfeld, but that was the high point for the Today Sponge in recent years. Now, 12 years after Wyeth stopped making it, a new owner is looking to relaunch the contraceptive sponge to a highly-segmented swatch of consumers with brighter packaging, print ads and a Web site.